...
首页> 外文期刊>Modern rheumatology >Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: A retrospective multicenter study in Japan
【24h】

Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: A retrospective multicenter study in Japan

机译:接受生物制剂治疗的类风湿关节炎患者的肺非结核分枝杆菌病的放射学特征和治疗反应:日本的一项回顾性多中心研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective This study was performed to evaluate the radiological features of and therapeutic responses to pulmonary disease caused by nontuberculous mycobacteria (NTM) in the setting of biological therapy for rheumatoid arthritis (RA). Methods We conducted a retrospective chart review of 13 patients from multiple centers who had developed pulmonary NTM disease during biological therapy for RA, including infliximab, etanercept, adalimumab, and tocilizumab. Results Most cases were asymptomatic or resulted in only common-cold-like symptoms. Abnormalities in computed tomography (CT) imaging were protean and frequently overlapped. The most predominant pattern was nodular/ bronchiectatic disease (six cases), followed by alveolar infiltrate (three cases), cavitary disease (two cases), and pulmonary nodules (two cases). In most cases, pulmonary NTM disease had spread from a preexisting lesion; in particular, bronchial/bronchiolar abnormalities. In three cases, one or more nodular lesions with or without calcification were a focus of disease. Following the discontinuation of biological agents, most patients responded to anti-NTM therapy. Two patients showed no exacerbation in the absence of any anti-NTM therapy. In one patient, restarting tocilizumab therapy while continuing to receive adequate anti-NTM therapy produced a favorable outcome. In two other patients with a previous history of pulmonary NTM disease, introducing biological therapy led to recurrence, but anti-NTM therapy was effective in these patients. Conclusion CT abnormalities of pulmonary NTM disease in RA patients receiving biological therapy were variable, but were not unique to this clinical setting. NTM disease can spread from preexisting structural abnormalities, even if they are minute. Contrary to our expectations, the therapeutic outcomes of pulmonary NTM disease were favorable in these patients.
机译:目的进行本研究,以评估类风湿关节炎(RA)的生物治疗背景下非结核分枝杆菌(NTM)引起的肺部疾病的放射学特征和对治疗的反应。方法我们对来自多个中心的13名在RA生物疗法期间出现肺NTM疾病的患者进行了回顾性图表回顾,包括英夫利昔单抗,依那西普,阿达木单抗和托珠单抗。结果大多数病例无症状或仅引起普通感冒症状。计算机断层扫描(CT)成像异常是蛋白质,并且经常重叠。最主要的模式是结节/支气管疾病(6例),其次是肺泡浸润(3例),空洞疾病(2例)和肺结节(2例)。在大多数情况下,肺NTM疾病已从先前存在的病变扩散;特别是支气管/支气管异常。在三例中,有或无钙化的一个或多个结节性病变是疾病的重点。停用生物制剂后,大多数患者对抗NTM治疗有反应。两名患者在未进行任何抗NTM治疗的情况下均未加重病情。在一名患者中,重新开始使用tocilizumab治疗,同时继续接受足够的抗NTM治疗产生了良好的效果。在另外两名有肺NTM病史的患者中,采用生物疗法可导致复发,但抗NTM疗法对这些患者有效。结论在接受生物疗法的RA患者中,肺NTM疾病的CT异常是可变的,但不是这种临床情况所独有的。 NTM疾病可以从先前存在的结构异常中传播,即使它们很小。与我们的预期相反,这些患者的肺NTM疾病的治疗效果良好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号